Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Risk Factors for Lymph Node Metastasis in Pathological T1b Colorectal Cancer

ATSUSHI NAITO, KAZUYA IWAMOTO, MASAHISA OHTSUKA, MITSUNOBU IMASATO, YUJIRO NAKAHARA, MANABU MIKAMORI, KENTA FURUKAWA, JEONGHO MOON, TADAFUMI ASAOKA, KENTARO KISHI and HIROKI AKAMATSU
In Vivo March 2021, 35 (2) 987-991; DOI: https://doi.org/10.21873/invivo.12341
ATSUSHI NAITO
Department of Surgery, Osaka Police Hospital, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: naito.atsu{at}gmail.com
KAZUYA IWAMOTO
Department of Surgery, Osaka Police Hospital, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MASAHISA OHTSUKA
Department of Surgery, Osaka Police Hospital, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MITSUNOBU IMASATO
Department of Surgery, Osaka Police Hospital, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUJIRO NAKAHARA
Department of Surgery, Osaka Police Hospital, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MANABU MIKAMORI
Department of Surgery, Osaka Police Hospital, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENTA FURUKAWA
Department of Surgery, Osaka Police Hospital, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JEONGHO MOON
Department of Surgery, Osaka Police Hospital, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TADAFUMI ASAOKA
Department of Surgery, Osaka Police Hospital, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KENTARO KISHI
Department of Surgery, Osaka Police Hospital, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIROKI AKAMATSU
Department of Surgery, Osaka Police Hospital, Osaka, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Background/Aim: The rate of lymph node metastasis (LNM) of colorectal carcinoma (CRC) with a submucosal (SM) invasion depth of 1000 µm or more can reach 12.5%, which is the most common reason for additional resection in daily practice. Other studies have reported that the rate of LNM is less than 2%, regardless of the depth of invasion, if the lesions show good histology, lymphovascular infiltration is negative, and tumor budding is limited. The purpose of this study was to investigate new risk factors for LNM in T1b colorectal cancer. Patients and Methods: The 239 patients who were diagnosed with pathological T1b CRC after colorectal surgical resection at the Osaka Police Hospital in Japan between January 2008 and December 2018 were retrospectively reviewed in this study. Results: The LNM rate was 11.3% (27/239). The variables identified as being significant factors using multivariate analysis were: i) lymphatic invasion (Ly)-positive [odds ratio (OR)=5.97; 95% confidence interval (CI)=2.27-15.74], ii) female gender (OR=3.49; 95%CI=1.38-8.85), and iii) left-sided colorectal involvement (OR=4.98; 95%CI=1.22-20.39). If none of these risk factors were present with T1b, the LNM rate was 0% (0/28). Conclusions: Ly-positive, female gender, and left-sided colorectal involvement could be risk factors for LNM in T1b CRC.

  • Lymph node metastasis
  • risk factor
  • T1b colorectal cancer

Colorectal cancer (CRC) is the third most common cancer in the world (1). With the increase in the implementation of CRC screening programs, the frequency of early cancer is expected to increase. (2). The recently reported favorable long-term results of endoscopic resection (ER) for T1 CRC suggest that superficial T1 CRC with a submucosal (SM) invasion depth of less than 1000 μm may have a very low risk of metastasis (3, 4). ER is considered an attractive therapeutic option for T1 CRC because of its less invasive profile compared to surgical resection (5). Surgical resection is recommended when the vertical margin is positive. However, if the vertical margin is negative, surgical resection is recommended in cases of: i) T1b (depth of SM invasion ≥1000 µm), ii) lymphovascular invasion-positive, iii) undifferentiated histopathological types (poorly differentiated adenocarcinoma, signet-ring cell carcinoma, or mucinous carcinoma), or iv) budding grade of BD2/3 (6). According to the results of a study by the Japanese Society for Cancer of the Colon and Rectum (JSCCR), the lymph node metastasis (LNM) rate of CRC with an SM invasion depth of 1000 µm or more was 12.5% (7). On the other hand, several studies have reported that the rate of LNM was less than 2%, regardless of the depth of invasion, if the lesions showed good histology, no lymphovascular infiltration, and limited tumor budding (8, 9). In a study of 548 cases of T1 cancer, deep invasion was found in 89.8% of the additional resections (10), which is the most common reason for additional resection in daily practice.

The purpose of this study was to investigate new risk factors for LNM in T1b CRC.

Patients and Methods

Patient selection, data extraction, and definitions. Patients diagnosed with pathological T1b CRC after colorectal surgical resection at the Osaka Police Hospital in Japan between January 2008 and December 2018 were included in this study. The exclusion criteria were i) synchronous CRC, ii) concomitant surgical procedures for other cancers, iii) local recurrence after ER, iv) distant metastasis, or v) treatment other than surgery.

Information on various clinicopathological factors of the patients, including sex, age, tumor location, histological type, and LNM, was obtained from medical records and retrospectively analyzed. Histological types were classified as either differentiated (differentiated papillary, well or moderately differentiated tubular adenocarcinoma) or undifferentiated (undifferentiated and poorly differentiated adenocarcinoma, signet-ring cell carcinoma, or mucinous carcinoma). Tumor budding was not included due to low reporting rate in the pathology reports.

Tumors arising from the cecum to the ascending and transverse colon were defined as tumors on the right side, and tumors arising from the descending colon to the rectum were defined as tumors on the left side.

This study was reviewed and approved by the institutional review boards of the participating institutions. Written consent was obtained from each patients.

Statistical analysis. Clinicopathological factors were analyzed using Pearson’s Chi-squared test and Fisher’s exact test. Variables found to be significant in univariate analysis were analyzed by multivariate logistic regression analysis. If the 95% confidence interval (CI) for the odds ratio (OR) did not include 1.0, and if p-value<0.05, the difference was considered significant. All statistical analyses were performed using JMP version 14.0 (SAS Institute, Cary, NC).

Results

The baseline characteristics of all patients (n=239) are presented in Table I. A total of 142 patients (59.4%) were treated with colorectal surgical resection alone as an initial treatment (surgery alone), and 97 patients (40.6%) underwent additional colorectal surgical resection after initial ER (surgery after ER). The number of patients positive for LNM was 27 (11.3%).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table I.

Baseline characteristics.

Risk factors for LNM in T1b CRC. Univariate analysis showed a significant difference in four risk factors (Table II), and the factors that were significantly different on multivariate analysis were: i) lymphatic invasion (Ly)-positive (OR=5.97; 95%CI=2.27-15.74), ii) female gender (OR=3.49; 95% CI=1.38-8.85), and iii) left-sided colorectal involvement (OR=4.98; 95%CI=1.22-20.39). Of these variables, Ly-positive had the highest OR (Table III).

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table II.

Univariate analysis of the risk factors for lymph node metastasis.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table III.

Multivariate analysis of the risk factors for lymph node metastasis.

The LNM rates for each combination of risk factors in this study (Ly-positive, female gender, left-sided colorectal involvement) are shown in Table IV. If no risk factors were present with T1b (depth of SM invasion ≥1,000 µm), the rate of LNM was 0%; if one risk factor was present, the rate was 2.7%; if two risk factors were present, the rate was 22.8%; and if all three risk factors were present, the rate was 31.6%. Thus, the rate of LNM increased with the number of positive risk factors, and when only T1b without the three risk factors was present, it was 0%.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table IV.

Relationship between the number of risk factors in the present study and lymph node metastasis.

Discussion

It has been reported that the rate of LNM is 0% if the depth of invasion is <1,000 μm (7). In routine practice, T1b is the most commonly encountered reason for additional resection of T1 CRC (10). Colorectal surgery is still associated with considerable morbidity and mortality (11, 12). Identification of factors that determine the indication for surgery is desperately needed. In the present study, three risk factors: i) Ly-positive, ii) female gender, and iii) left-sided colorectal involvement, were identified for LNM. In our study, when T1b was the only pathological risk factor in T1 CRC, the rate of LNM was extremely low, at 4.3%. In the absence of the three factors identified in the present study, the LNM rate was even less, at 0%. The three risk factors that were identified seemed to correlate better with LNM than those reported in the JSCCR guidelines (6).

Ly-positive had the highest odds ratio. The relationship between this factor and LNM has been widely reported and appears to be reliable (13). There was no significant variation in the extend of venous invasion with respect to histological type in the present study. This may be due to the small sample size. Tumor budding was not included, due to their low rates found in the pathology reports.

Second, female patients were at a higher risk of LNM compared to male patients. This has been shown in another large study (14). However, there were no significant differences between males and females with location, age, morphology, or pathological factors in that paper. There have been several other reports on the association between patient sex and LNM (7, 15, 16), however, no significant relationship between patient sex and LNM risk in patients with T1 cancer was demonstrated, and further studies are required to clarify the lack or verification of this association.

Furthermore, left-sided colorectal tumor was a risk factor. Although the relationship between LNM and left-right body axis differences has not been reported, a high incidence of LNM has been reported in the rectum (17). The rectum has a well-developed anatomical collateral circulation, which may increase the likelihood of an invading tumor encountering a vessel. The left-sided colorectum contains the rectum, which may explain the difference in LNM.

This study has certain limitations, such as the small number of patients, and the fact that it was a retrospective, single-institute study. Thus, further large and multi-institutional studies are needed to confirm our findings.

In conclusion, we found that when T1b is the only pathological risk factor in T1 CRC, the rate of LNM is exceedingly low, however, Ly-positive, female, and left-sided colorectal involvement are potential risk factors for LNM.

Acknowledgements

The Authors are grateful for the efforts of our past and present members of the hospital.

Footnotes

  • Authors’ Contributions

    Study concept and design, data analysis and interpretation, statistical analysis and manuscript preparation were done by AN. Data acquisition was done by MO, quality control of data and algorithms were done by MI and AN. Manuscript editing was done by HA and manuscript review by KI, YN, MM, KF, JM, TA, and KK.

  • This article is freely accessible online.

  • Conflicts of Interest

    The Authors declare no conflicts of interest associated with this manuscript.

  • Received October 26, 2020.
  • Revision received December 4, 2020.
  • Accepted December 10, 2020.
  • Copyright © 2021 The Author(s). Published by the International Institute of Anticancer Research.

References

  1. ↵
    1. Bray F,
    2. Ferlay J,
    3. Soerjomataram I,
    4. Siegel RL,
    5. Torre LA and!
    6. Jemal A
    : Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6): 394-424, 2018. PMID: 30207593. DOI: 10.3322/caac.21492
    OpenUrlCrossRefPubMed
  2. ↵
    1. Gupta AK,
    2. Melton LJ,
    3. Petersen GM,
    4. Timmons LJ,
    5. Vege SS,
    6. Harmsen WS,
    7. Diehl NN,
    8. Zinsmeister AR and
    9. Ahlquist DA
    : Changing trends in the incidence, stage, survival, and screen-detection of colorectal cancer: A population-based study. Clin Gastroenterol Hepatol 3(2): 150-158, 2005. PMID: 15704049. DOI: 10.1016/s1542-3565(04)00664-0
    OpenUrlCrossRefPubMed
  3. ↵
    1. Choi JY,
    2. Jung SA,
    3. Shim KN,
    4. Cho WY,
    5. Keum B,
    6. Byeon JS,
    7. Huh KC,
    8. Jang BI,
    9. Chang DK,
    10. Jung HY and
    11. Kong KA
    : Meta-analysis of predictive clinicopathologic factors for lymph node metastasis in patients with early colorectal carcinoma. J Korean Med Sci 30(4): 398-406, 2015. PMID: 25829807. DOI: 10.3346/jkms.2015.30.4.398
    OpenUrlCrossRef
  4. ↵
    1. Wada H,
    2. Shiozawa M,
    3. Katayama K,
    4. Okamoto N,
    5. Miyagi Y,
    6. Rino Y,
    7. Masuda M and
    8. Akaike M
    : Systematic review and meta-analysis of histopathological predictive factors for lymph node metastasis in T1 colorectal cancer. J Gastroenterol 50(7): 727-734, 2015. PMID: 25725617. DOI: 10.1007/s00535-015-1057-0
    OpenUrlCrossRefPubMed
  5. ↵
    1. Sako T,
    2. Kudo S-E,
    3. Miyachi H,
    4. Wakamura K,
    5. Igarashi K,
    6. Misawa M,
    7. Mori Y,
    8. Kudo T,
    9. Hayashi T,
    10. Katagiri A,
    11. Ishida F,
    12. Azuma T,
    13. Inoue H and
    14. Hamatani S
    : A novel ability of endocytoscopy to diagnose histological grade of differentiation in T1 colorectal carcinomas. Endoscopy 50(1): 69-74, 2018. PMID: 28962043. DOI: 10.1055/s-0043-117403
    OpenUrlCrossRef
  6. ↵
    1. Hashiguchi Y,
    2. Muro K,
    3. Saito Y,
    4. Ito Y,
    5. Ajioka Y,
    6. Hamaguchi T,
    7. Hasegawa K,
    8. Hotta K,
    9. Ishida H,
    10. Ishiguro M,
    11. Ishihara S,
    12. Kanemitsu Y,
    13. Kinugasa Y,
    14. Murofushi K,
    15. Nakajima TE,
    16. Oka S,
    17. Tanaka T,
    18. Taniguchi H,
    19. Tsuji A,
    20. Uehara K,
    21. Ueno H,
    22. Yamanaka T,
    23. Yamazaki K,
    24. Yoshida M,
    25. Yoshino T,
    26. Itabashi M,
    27. Sakamaki K,
    28. Sano K,
    29. Shimada Y,
    30. Tanaka S,
    31. Uetake H,
    32. Yamaguchi S,
    33. Yamaguchi N,
    34. Kobayashi H,
    35. Matsuda K,
    36. Kotake K and
    37. Sugihara K
    : Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol 25(1): 1-42, 2020. PMID: 31203527. DOI: 10.1007/s10147-019-01485-z
    OpenUrlCrossRef
  7. ↵
    1. Kitajima K,
    2. Fujimori T,
    3. Fuji S,
    4. Takeda J,
    5. Ohkura Y,
    6. Kawamata H,
    7. Kumamoto T,
    8. Ishiguro S,
    9. Kato Y,
    10. Shimoda T,
    11. Iwashita A,
    12. Ajioka Y,
    13. Watanabe H,
    14. Watanabe T,
    15. Muto T and
    16. Nagasako K
    : Correlations between lymph node metastasis and depth of submucosal invasion in submucosal invasive colorectal carcinoma: A Japanese collaborative study. J Gastroenterol 39(6): 534-543, 2004. PMID: 15235870. DOI: 10.1007/s00535-004-1339-4
    OpenUrlCrossRefPubMed
  8. ↵
    1. Nakadoi K,
    2. Tanaka S,
    3. Kanao H,
    4. Terasaki M,
    5. Takata S,
    6. Oka S,
    7. Yoshida S,
    8. Arihiro K and
    9. Chayama K
    : Management of T1 colorectal carcinoma with special reference to criteria for curative endoscopic resection. J Gastroenterol Hepatol 27(6): 1057-1062, 2012. PMID: 22142484. DOI: 10.1111/j.1440-1746.2011.07041.x
    OpenUrlCrossRefPubMed
  9. ↵
    1. Kobayashi H,
    2. Higuchi T,
    3. Uetake H,
    4. Iida S,
    5. Ishikawa T,
    6. Ishiguro M and
    7. Sugihara K
    : Resection with en bloc removal of regional lymph node after endoscopic resection for T1 colorectal cancer. Ann Surg Oncol 19(13): 4161-4167, 2012. PMID: 22772868. DOI: 10.1245/s10434-012-2471-7
    OpenUrlCrossRefPubMed
  10. ↵
    1. Yamaoka Y,
    2. Imai K,
    3. Shiomi A,
    4. Kagawa H,
    5. Hino H,
    6. Yamakawa Y,
    7. Yamaguchi T,
    8. Kinugasa Y,
    9. Kishida Y,
    10. Ito S,
    11. Hotta K and
    12. Imai T
    : Endoscopic resection of T1 colorectal cancer prior to surgery does not affect surgical adverse events and recurrence. Surg Endosc 34(11): 5006-5016, 2019. PMID: 31820150. DOI: 10.1007/s00464-019-07295-8
    OpenUrlCrossRef
  11. ↵
    1. Panis Y,
    2. Maggiori L,
    3. Caranhac G,
    4. Bretagnol F and
    5. Vicaut E
    : Mortality after colorectal cancer surgery: A french survey of more than 84,000 patients. Ann Surg 254(5): 738-743, 2011. PMID: 21997816. DOI: 10.1097/SLA.0b013e31823604ac
    OpenUrlCrossRefPubMed
  12. ↵
    1. Wexner SD
    : Postoperative mortality and morbidity in French patients undergoing colorectal surgery—invited critique. Arch Surg 140(3): 284, 2005. PMID: 15781793. DOI: 10.1001/archsurg.140.3.278
    OpenUrlCrossRef
  13. ↵
    1. Watanabe T,
    2. Muro K,
    3. Ajioka Y,
    4. Hashiguchi Y,
    5. Ito Y,
    6. Saito Y,
    7. Hamaguchi T,
    8. Ishida H,
    9. Ishiguro M,
    10. Ishihara S,
    11. Kanemitsu Y,
    12. Kawano H,
    13. Kinugasa Y,
    14. Kokudo N,
    15. Murofushi K,
    16. Nakajima T,
    17. Oka S,
    18. Sakai Y,
    19. Tsuji A,
    20. Uehara K,
    21. Ueno H,
    22. Yamazaki K,
    23. Yoshida M,
    24. Yoshino T,
    25. Boku N,
    26. Fujimori T,
    27. Itabashi M,
    28. Koinuma N,
    29. Morita T,
    30. Nishimura G,
    31. Sakata Y,
    32. Shimada Y,
    33. Takahashi K,
    34. Tanaka S,
    35. Tsuruta O,
    36. Yamaguchi T,
    37. Yamaguchi N,
    38. Tanaka T,
    39. Kotake K and
    40. Sugihara K
    : Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol 23(1): 1-34, 2018. PMID: 28349281. DOI: 10.1007/s10147-017-1101-6
    OpenUrlCrossRefPubMed
  14. ↵
    1. Miyachi H,
    2. Kudo SE,
    3. Ichimasa K,
    4. Hisayuki T,
    5. Oikawa H,
    6. Matsudaira S,
    7. Kouyama Y,
    8. Kimura YJ,
    9. Misawa M,
    10. Mori Y,
    11. Ogata N,
    12. Kudo T,
    13. Kodama K,
    14. Hayashi T,
    15. Wakamura K,
    16. Katagiri A,
    17. Baba T,
    18. Hidaka E,
    19. Ishida F,
    20. Kohashi K and
    21. Hamatani S
    : Management of T1 colorectal cancers after endoscopic treatment based on the risk stratification of lymph node metastasis. J Gastroenterol Hepatol 31(6): 1126-1132, 2016. PMID: 26641025. DOI: 10.1111/jgh.13257
    OpenUrlCrossRef
  15. ↵
    1. Nakadoi K,
    2. Oka S,
    3. Tanaka S,
    4. Hayashi N,
    5. Terasaki M,
    6. Arihiro K,
    7. Shimamoto F and
    8. Chayama K
    : Condition of muscularis mucosae is a risk factor for lymph node metastasis in T1 colorectal carcinoma. Surg Endosc 28(4): 1269-1276, 2014. PMID: 24281433. DOI: 10.1007/s00464-013-3321-9
    OpenUrlCrossRef
  16. ↵
    1. Samuolis N,
    2. Samalavicius NE,
    3. Dulskas A,
    4. Markelis R,
    5. Lunevicius R,
    6. Mickys U and
    7. Ringeleviciute U
    : Surgical or endoscopic management of malignant colon polyps. ANZ J Surg 88(12): E824-E828, 2018. PMID: 30347496. DOI: 10.1111/ans.14846
    OpenUrlCrossRef
  17. ↵
    1. Yasue C,
    2. Chino A,
    3. Takamatsu M,
    4. Namikawa K,
    5. Ide D,
    6. Saito S,
    7. Igarashi M and
    8. Fujisaki J
    : Pathological risk factors and predictive endoscopic factors for lymph node metastasis of T1 colorectal cancer: a single-center study of 846 lesions. J Gastroenterol 54(8): 708-717, 2019. PMID: 30810812. DOI: 10.1007/s00535-019-01564-y
    OpenUrlCrossRef
PreviousNext
Back to top

In this issue

In Vivo
Vol. 35, Issue 2
March-April 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on In Vivo.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Risk Factors for Lymph Node Metastasis in Pathological T1b Colorectal Cancer
(Your Name) has sent you a message from In Vivo
(Your Name) thought you would like to see the In Vivo web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
10 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Risk Factors for Lymph Node Metastasis in Pathological T1b Colorectal Cancer
ATSUSHI NAITO, KAZUYA IWAMOTO, MASAHISA OHTSUKA, MITSUNOBU IMASATO, YUJIRO NAKAHARA, MANABU MIKAMORI, KENTA FURUKAWA, JEONGHO MOON, TADAFUMI ASAOKA, KENTARO KISHI, HIROKI AKAMATSU
In Vivo Mar 2021, 35 (2) 987-991; DOI: 10.21873/invivo.12341

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Risk Factors for Lymph Node Metastasis in Pathological T1b Colorectal Cancer
ATSUSHI NAITO, KAZUYA IWAMOTO, MASAHISA OHTSUKA, MITSUNOBU IMASATO, YUJIRO NAKAHARA, MANABU MIKAMORI, KENTA FURUKAWA, JEONGHO MOON, TADAFUMI ASAOKA, KENTARO KISHI, HIROKI AKAMATSU
In Vivo Mar 2021, 35 (2) 987-991; DOI: 10.21873/invivo.12341
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Tumor Budding as a Predictive Marker of Relapse and Survival in Patients With Stage II Colon Cancer
  • Google Scholar

More in this TOC Section

  • Association Between Dipeptidyl Peptidase-4 Inhibitor Use and Acute Kidney Injury in Patients With Diabetes Mellitus: A Disproportionality Analysis Based on the FAERS
  • Expression Patterns of T-cell immunoreceptor With Ig and ITIM domains (TIGIT) in Classical Hodgkin Lymphoma: A Clinicopathological Study
  • Older Age and Outcomes of Intravesical Bacillus Calmette-Guérin for Non-muscle-invasive Bladder Cancer
Show more Clinical Studies

Keywords

  • lymph node metastasis
  • risk factor
  • T1b colorectal cancer
In Vivo

© 2026 In Vivo

Powered by HighWire